Trial Profile
Phase I long-term population pharmacokinetic trial of RHB 104.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Oct 2016
Price :
$35
*
At a glance
- Drugs Clarithromycin/clofazimine/rifabutin (Primary)
- Indications Crohn's disease
- Focus Pharmacokinetics; Registrational
- Sponsors RedHill Biopharma
- 07 Jan 2014 New trial record